Wells Fargo Maintains Overweight on Alkermes, Raises Price Target to $43
Alkermes Public Limited Company -1.92%
Alkermes Public Limited Company ALKS | 33.22 | -1.92% |
Wells Fargo analyst Benjamin Burnett maintains Alkermes (NASDAQ:
ALKS) with a Overweight and raises the price target from $37 to $43.
